ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) CEO Nikhil Lalwani Sells 16,292 Shares

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Get Free Report) CEO Nikhil Lalwani sold 16,292 shares of the stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $67.13, for a total value of $1,093,681.96. Following the transaction, the chief executive officer now directly owns 411,629 shares in […]

Related Keywords

Canada ,United States ,Blackrock ,Nova Scotia ,Nikhil Lalwani ,Ani Pharmaceuticals Inc ,Blackrock Inc ,Vanguard Group Inc ,Pharmaceuticals Inc ,Global Alpha Capital Management Ltd ,Nasdaq ,Dimensional Fund Advisors ,Pharmaceuticals Daily ,Pharmaceuticals Stock ,Get Free Report ,Capital Management ,Fund Advisors ,Global Alpha Capital Management ,Alpha Capital Management ,Ani Pharmaceuticals ,Nasdaq Anip ,Manip ,Medical ,Insider Trading ,Nsider Trades ,Stocks ,